(Q36055538)

11 August 2017

1 reference

title

The auto-regulation model: a unified concept of how HIV regulates its infectivity, pathogenesis and persistence (English)

1 reference

11 August 2017

1 reference

Layne SP

1

1 reference

PubMed ID

1573317

11 August 2017

Dembo M

series ordinal

2

1 reference

11 August 2017

1 January 1992

1 reference

International Reviews of Immunology

11 August 2017

1 reference

11 August 2017

8

1 reference

11 August 2017

1-32

1 reference

11 August 2017

1

1 reference

Quantifying the infectivity of human immunodeficiency virus

11 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

HIV requires multiple gp120 molecules for CD4-mediated infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Cell adhesion. Competition between nonspecific repulsion and specific bonding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

A multi-hit model for the neutralization of animal viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Pathogenesis of infection with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Dissociation of gp120 from HIV-1 virions induced by soluble CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Loss of envelope antigens of HTLV-III/LAV, a factor in AIDS pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

HIV infection is blocked in vitro by recombinant soluble CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Crystal structure of an HIV-binding recombinant fragment of human CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Quantitative infectivity assay for HIV-1 and-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Statistical data analysis in the computer age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Physics of chemoreception

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Competition between solution and cell surface receptors for ligand. Dissociation of hapten bound to surface antibody in the presence of solution antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

The molecular biology of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Discrimination Between Intracellular Uptake and Surface Adhesion of Bacterial Pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Modulation of lentivirus replication by antibodies. Non-neutralizing antibodies to caprine arthritis-encephalitis virus enhance early stages of infection in macrophages, but do not cause increased production of virions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Dextran sulphate, a potent anti-HIV agent in vitro having synergism with zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Human immunodeficiency virus can productively infect cultured human glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Inhibition of Entry of HIV-1 in Neural Cell Lines by Antibodies Against Galactosyl Ceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Plasma viremia in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Mononuclear phagocytes and the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Highly efficient neutralization of HIV with recombinant CD4-immunoglobulin molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Designing CD4 immunoadhesins for AIDS therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Biological properties of a CD4 immunoadhesin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of the viral life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Lentiviruses of animals are biological models of the human immunodeficiency viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell l

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

In vitro synthesis of human immunodeficiency virus-specific antibodies in peripheral blood lymphocytes of infants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Mechanisms of Neutralization of Animal Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Development and testing of AIDS vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Modern vaccines. Human immunodeficiency virus and AIDS: challenges and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Is NIH failing an AIDS "challenge"?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Poliovirus mutants resistant to neutralization with soluble cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

T cells can present antigens such as HIV gp120 targeted to their own surface molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Biologically diverse molecular variants within a single HIV-1 isolate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Single amino-acid changes in HIV envelope affect viral tropism and receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

Complexities and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209056638

10.3109/08830189209056638

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

1573317